Quick Answer
HOOKIPA Pharma Inc. reported Total Assets of $82.55 million for fiscal year 2024.
HOOKIPA Pharma Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $82.55M | -48.8% |
| 2023 | $161.34M | -5.3% |
| 2022 | $170.45M | +35.2% |
| 2021 | $126.05M | -32.9% |
| 2020 | $187.82M | +30.7% |
| 2019 | $143.75M | +110.6% |
| 2018 | $68.25M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | $61.26M | -58.0% | -25.8% |
| December 31, 2024 | $82.55M | -48.8% | -24.8% |
| September 30, 2024 | $109.73M | -33.1% | -12.2% |
| June 30, 2024 | $125.05M | -34.6% | -14.3% |
| March 31, 2024 | $145.87M | -10.6% | -9.6% |
| December 31, 2023 | $161.34M | -5.3% | -1.6% |
| September 30, 2023 | $164.01M | +8.2% | -14.2% |
| June 30, 2023 | $191.11M | +11.0% | +17.2% |
- HOOKIPA Pharma Inc. showed a decrease of -48.8% in Total Assets compared to the prior fiscal year.
- Over the 2018–2024 period, HOOKIPA Pharma Inc.’s total assets has grown by 20.9% (from $68.25 million to $82.55 million).
- The most recent figure is from HOOKIPA Pharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: